Financial News Feed

Today ADMA ranks # as SELL CANDIDATE.
Today ADMA ranks # as SELL CANDIDATE.

ADMA stock ADMA Biologics Inc

ADMA stock
ADMA Biologics Inc

Putting shares of ADMA Biologics, Inc. (NASDAQ:ADMA) at the forefront, let’s drill down into some key metrics. ADMA Biologics, Inc. (NASDAQ:ADMA)’s shares may have a significant upside to the cons...

Read more

Adma Biologics (ADMA) shares opened the last session at 3.36, touching a high of 3.603 and a low of 3.35 , yielding a change of 0.00. The latest reading places the stock below the Ichimoku cloud which...

Read more

Investors sentiment decreased to 1.8 in 2018 Q3. Its down 1.87, from 3.67 in 2018Q2. It is negative, as 4 investors sold ADMA Biologics, Inc. shares while 11 reduced holdings. 7 funds opened positions...

Read more

Sentiment for ADMA BIOLOGICS (NASDAQ:ADMA) ADMA BIOLOGICS (NASDAQ:ADMA) institutional sentiment decreased to 1.8 in 2018 Q3. Its down -1.87, from 3.67 in 2018Q2. The ratio has worsened, as 27 investme...

Read more

Ichimoku traders are closely watching shares of Adma Biologics (ADMA) as the equity’s price has tipped below the Tenkan moving average line, creating an environment ripe for a potential near-term re...

Read more

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a compan...

Read more

Shares of Adma Biologics (ADMA) are heading in a near-term negative direction as the most recent close of the company has stayed below the Balance Step. The Balance Step reading takes into account the...

Read more

Brokerages expect that ADMA Biologics Inc (NASDAQ:ADMA) will post sales of $5.56 million for the current quarter, according to Zacks. Four analysts have made estimates for ADMA Biologics’ earnings, ...

Read more

ADMA Biologics, Inc. (NASDAQ:ADMA)’ stock is holding above their moving averages, indicating a postitive uptrend for Healthcare company. Investors are generally searching for a stock market strategy...

Read more

Stock market players may have differing opinions on which type of research approach is best. Individual investors who prefer buy and hold strategies may be more likely to be studying the fundamentals....

Read more

ADMA Biologics, Inc. (NasdaqCM:ADMA) has a current MF Rank of 17245. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at...

Read more

In reviewing some key ratios and quant data for NH Hotel Group, S.A. (BME:NHH), we note that the mother of all ratios (Return on Equity) stands at 0.079261 for the firm. ROE reveals what percentage of...

Read more

Taking Aim at Adma Biologics (ADMA) Shares
08:11pm, Thursday, 10'th Jan 2019
Adma Biologics (ADMA) shares have experienced bearish momentum as the Average True Range of the shares have trended downward over the past 10 sessions. Based on a recent trade, the current level of th...

Read more

Shares of Adma Biologics (ADMA) are nearing some key technical levels as the Rank Correlation indicator has trending higher over the past few sessions, nearing potential overbought territory. Crossing...

Read more

The Current Ratio of ADMA Biologics, Inc. (NasdaqCM:ADMA) is 6.32. The Current Ratio is used by investors to determine whether a company can pay short term and long term debts. The current ratio looks...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank